Agency Forms Undergoing Paperwork Reduction Act Review

Citation84 FR 53441
Record Number2019-21753
Published date07 October 2019
SectionNotices
CourtCenters For Disease Control And Prevention,Health And Human Services Department
Federal Register, Volume 84 Issue 194 (Monday, October 7, 2019)
[Federal Register Volume 84, Number 194 (Monday, October 7, 2019)]
                [Notices]
                [Pages 53441-53444]
                From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
                [FR Doc No: 2019-21753]
                =======================================================================
                -----------------------------------------------------------------------
                DEPARTMENT OF HEALTH AND HUMAN SERVICES
                Centers for Disease Control and Prevention
                [30Day-19-0666]
                Agency Forms Undergoing Paperwork Reduction Act Review
                 In accordance with the Paperwork Reduction Act of 1995, the Centers
                for Disease Control and Prevention (CDC) has submitted the information
                collection request titled National Healthcare Safety Network (NHSN) to
                the Office of Management and Budget (OMB) for review and approval. CDC
                previously published a ``Proposed Data Collection Submitted for Public
                Comment and Recommendations'' notice on June 5, 2019 to obtain comments
                from the public and affected agencies. CDC received two comments
                related to the previous notice. This notice serves to allow an
                additional 30 days for public and affected agency comments.
                 CDC will accept all comments for this proposed information
                collection project. The Office of Management and Budget is particularly
                interested in comments that:
                 (a) Evaluate whether the proposed collection of information is
                necessary for the proper performance of the functions of the agency,
                including whether the information will have practical utility;
                 (b) Evaluate the accuracy of the agencies estimate of the burden of
                the proposed collection of information, including the validity of the
                methodology and assumptions used;
                 (c) Enhance the quality, utility, and clarity of the information to
                be collected;
                 (d) Minimize the burden of the collection of information on those
                who are to respond, including, through the use of appropriate
                automated, electronic, mechanical, or other technological collection
                techniques or other forms of information technology, e.g., permitting
                electronic submission of responses; and
                 (e) Assess information collection costs.
                 To request additional information on the proposed project or to
                obtain a copy of the information collection plan and instruments, call
                (404) 639-7570 or send an email to [email protected]. Direct written comments
                and/or suggestions regarding the items contained in this notice to the
                Attention: CDC Desk Officer, Office of Management and Budget, 725 17th
                Street NW, Washington, DC 20503 or by fax to (202) 395-5806. Provide
                written comments within 30 days of notice publication.
                Proposed Project
                 National Healthcare Safety Network (NHSN)--Revision--National
                Center for Emerging and Zoonotic Infection Diseases (NCEZID), Centers
                for Disease Control and Prevention (CDC).
                Background and Brief Description
                 The Division of Healthcare Quality Promotion (DHQP), National
                Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers
                for Disease Control and Prevention (CDC) collects data from healthcare
                facilities in the National Healthcare Safety Network (NHSN) under OMB
                Control Number 0920-0666. During the early stages of its development,
                NHSN began as a voluntary surveillance system in 2005 managed by DHQP.
                NHSN provides facilities, states, regions, and the nation with data
                necessary to identify problem areas, measure the progress of prevention
                efforts, and ultimately eliminate healthcare-associated infections
                (HAIs) nationwide. NHSN allows healthcare facilities to track blood
                safety errors and various healthcare-associated infection prevention
                practice methods such as healthcare personnel influenza vaccine status
                and corresponding infection control adherence rates.
                 NHSN currently has six components: Patient Safety (PS), Healthcare
                Personnel Safety (HPS), Biovigilance (BV), Long-Term Care Facility
                (LTCF), Outpatient Procedure (OPC), and the Dialysis Component. NHSN's
                new Neonatal Component is expected to launch during the summer of 2020.
                This component will focus on premature neonates and the healthcare-
                associated events that occur as a result of their prematurity. This
                component will be released with one module, which includes Late Onset-
                Sepsis and Meningitis. Late-onset sepsis (LOS) and Meningitis are
                common complications of extreme prematurity. Studies have indicated
                that 36% of extremely low gestational age (22-28 weeks) infants develop
                LOS and that 21% of very low birth weight infants surviving beyond
                three days of life will develop LOS. Meningitis occurs in 23% of
                bacteremic infants, but 38% of infants with a pathogen isolated from
                the cerebrospinal fluid may not have an organism isolated from blood.
                These infections are usually serious, causing a prolongation of
                hospital stay, increased cost, and risk of morbidity and mortality.
                 Some cases of LOS can be prevented through proper central line
                insertion and maintenance practices. These are addressed in the CDC's
                Healthcare Infection Control Practices Advisory Committee (CDC/HICPAC)
                Guidelines for the Prevention of Intravascular Catheter-Related
                Infections, 2011. However, almost one-third of LOS events in a quality-
                improvement study were not related to central-lines.
                [[Page 53442]]
                Prevention strategies for the non-central line-related infection events
                have yet to be fully defined, but include adherence to hand-hygiene,
                parent and visitor education, and optimum nursery design features.
                Other areas that likely influence the development of LOS include early
                enteral nutritional support and skin care practices. The data for this
                module will be electronically submitted, and manual data entry will not
                be available. This will allow more hospital personnel to be available
                to care for patients and will reduce annual burden across healthcare
                facilities. Additionally, LOS data will be utilized for prevention
                initiatives.
                 Data reported under the Patient Safety Component are used to
                determine the magnitude of the healthcare-associated adverse events and
                trends in the rates of the events, in the distribution of pathogens,
                and in the adherence to prevention practices. Data will help detect
                changes in the epidemiology of adverse events resulting from new
                medical therapies and changing patient risks. Additionally, reported
                data is being used to describe the epidemiology of antimicrobial use
                and resistance and to better understand the relationship of
                antimicrobial therapy to this rising problem. Under the Healthcare
                Personnel Safety Component, protocols and data on events--both positive
                and adverse--are used to determine (1) the magnitude of adverse events
                in healthcare personnel, and (2) compliance with immunization and
                sharps injuries safety guidelines. Under the Biovigilance Component,
                data on adverse reactions and incidents associated with blood
                transfusions are reported and analyzed to provide national estimates of
                adverse reactions and incidents. Under the Long-Term Care Facility
                Component, data is captured from skilled nursing facilities. Reporting
                methods under the LTCF component have been created by using forms from
                the PS Component as a model with modifications to specifically address
                the specific characteristics of LTCF residents and the unique data
                needs of these facilities reporting into NHSN. The Dialysis Component
                offers a simplified user interface for dialysis users to streamline
                their data entry and analyses processes as well as provide options for
                expanding in the future to include dialysis surveillance in settings
                other than outpatient facilities. The Outpatient Procedure Component
                (OPC) gathers data on the impact of infections and outcomes related to
                operative procedures performed in Ambulatory Surgery Centers (ASCs).
                The OPC is used to monitor two event types: Same Day Outcome Measures
                and Surgical Site Infections (SSIs).
                 NHSN has increasingly served as the operating system for HAI
                reporting compliance through legislation established by the states. As
                of March 2019, 36 states, the District of Columbia and the City of
                Philadelphia, Pennsylvania have opted to use NHSN as their primary
                system for mandated reporting. Reporting compliance is completed by
                healthcare facilities in their respective jurisdictions, with emphasis
                on those states and municipalities acquiring varying consequences for
                failure to use NHSN. Additionally, healthcare facilities in five U.S.
                territories (Puerto Rico, American Samoa, the U.S. Virgin Islands,
                Guam, and the Northern Mariana Islands) are voluntarily reporting to
                NHSN. Additional territories are projected to follow with similar use
                of NHSN for reporting purposes.
                 NHSN's data is used to aid in the tracking of HAIs and guide
                infection prevention activities/practices that protect patients. The
                Centers for Medicare and Medicaid Services (CMS) and other payers use
                these data to determine incentives for performance at healthcare
                facilities across the US and surrounding territories, and members of
                the public may use some protected data to inform their selection among
                available providers. Each of these parties is dependent on the
                completeness and accuracy of the data. CDC and CMS work closely and are
                fully committed to ensuring complete and accurate reporting, which are
                critical for protecting patients and guiding national, state, and local
                prevention priorities.
                 CMS collects some HAI data and healthcare personnel influenza
                vaccination summary data, which is done on a voluntary basis as part of
                its Fee-for-Service Medicare quality reporting programs, while others
                may report data required by a federal mandate. Facilities that fail to
                report quality measure data are subject to partial payment reduction in
                the applicable Medicare Fee-for-Service payment system. CMS links their
                quality reporting to payment for Medicare-eligible acute care
                hospitals, inpatient rehabilitation facilities, long-term acute care
                facilities, oncology hospitals, inpatient psychiatric facilities,
                dialysis facilities, and ambulatory surgery centers. Facilities report
                HAI data and healthcare personnel influenza vaccination summary data to
                CMS via NHSN as part of CMS's quality reporting programs to receive
                full payment. Still, many healthcare facilities, even in states without
                HAI reporting legislation, submit limited HAI data to NHSN voluntarily.
                 NHSN's data collection updates continue to support the incentive
                programs managed by CMS. For example, survey questions support
                requirements for CMS' quality reporting programs. Additionally, CDC has
                collaborated with CMS on a voluntary National Nursing Home Quality
                Collaborative, which focuses on recruiting nursing homes to report HAI
                data to NHSN and to retain their continued participation. This project
                has resulted in a significant increase in long-term care facilities
                reporting to NHSN. The collection of information is authorized by the
                Public Health Service Act (42 U.S.C. 242b, 242k, and 242m (d)).
                 The proposed changes in this new ICR include revisions made to 40
                NHSN data collection tools for a total of 76 data collection tools
                included in this ICR. The reporting burden decreased by 2,363,508 hours
                for a total estimated burden of 3,033,930 hours.
                 Estimated Annualized Burden Hours
                ----------------------------------------------------------------------------------------------------------------
                 Average
                 Number of Number of burden per
                 Respondent type Form No. & name respondents responses per response
                 respondent (hours)
                ----------------------------------------------------------------------------------------------------------------
                Healthcare Practitioner............ 57.100 NHSN Registration 2,000 1 5/60
                 Form.
                 57.101 Facility Contact 2,000 1 10/60
                 Information.
                 57.103 Patient Safety 5,175 1 75/60
                 Component--Annual Hospital
                 Survey.
                 57.105 Group Contact 1,000 1 5/60
                 Information.
                 57.106 Patient Safety 6,000 12 15/60
                 Monthly Reporting Plan.
                 57.108 Primary Bloodstream 5,775 5 38/60
                 Infection (BSI).
                [[Page 53443]]
                
                 57.111 Pneumonia (PNEU).... 1,800 30 30/60
                 57.112 Ventilator- 5,500 5 28/60
                 Associated Event.
                 57.113 Pediatric Ventilator- 334 120 30/60
                 Associated Event (PedVAE).
                 57.114 Urinary Tract 5,500 5 20/60
                 Infection (UTI).
                 57.115 Custom Event........ 600 91 35/60
                 57.116 Denominators for 220 12 249/60
                 Neonatal Intensive Care
                 Unit (NICU).
                 57.117 Denominators for 165 12 302/60
                 Specialty Care Area (SCA)/
                 Oncology (ONC).
                 57.118 Denominators for 5,500 60 302/60
                 Intensive Care Unit (ICU)/
                 Other locations (not NICU
                 or SCA).
                 57.120 Surgical Site 4,500 11 35/60
                 Infection (SSI).
                 57.121 Denominator for 4,500 680 10/60
                 Procedure.
                 57.122 HAI Progress Report 55 1 45/60
                 State Health Department
                 Survey.
                 57.123 Antimicrobial Use 1,500 12 5/60
                 and Resistance (AUR)-
                 Microbiology Data
                 Electronic Upload
                 Specification Tables.
                 57.124 Antimicrobial Use 2,000 12 5/60
                 and Resistance (AUR)-
                 Pharmacy Data Electronic
                 Upload Specification
                 Tables.
                 57.125 Central Line 500 213 25/60
                 Insertion Practices
                 Adherence Monitoring.
                 57.126 MDRO or CDI 720 12 30/60
                 Infection Form.
                 57.127 MDRO and CDI 5,500 29 15/60
                 Prevention Process and
                 Outcome Measures Monthly
                 Monitoring.
                 57.128 Laboratory- 4,800 87 20/60
                 identified MDRO or CDI
                 Event.
                 57.129 Adult Sepsis........ 50 250 25/60
                 57.137 Long-Term Care 2,220 1 120/60
                 Facility Component--Annual
                 Facility Survey.
                 57.138 Laboratory- 2,150 24 15/60
                 identified MDRO or CDI
                 Event for LTCF.
                 57.139 MDRO and CDI 2,200 12 20/60
                 Prevention Process
                 Measures Monthly
                 Monitoring for LTCF.
                 57.140 Urinary Tract 400 12 30/60
                 Infection (UTI) for LTCF.
                 57.141 Monthly Reporting 2,220 12 5/60
                 Plan for LTCF.
                 57.142 Denominators for 2,220 12 250/60
                 LTCF Locations.
                 57.143 Prevention Process 375 12 5/60
                 Measures Monthly
                 Monitoring for LTCF.
                 57.150 LTAC Annual Survey.. 500 1 70/60
                 57.151 Rehab Annual Survey. 1,200 1 70/60
                 57.200 Healthcare Personnel 50 1 480/60
                 Safety Component Annual
                 Facility Survey.
                 57.203 Healthcare Personnel .............. 1 5/60
                 Safety Monthly Reporting
                 Plan.
                 57.204 Healthcare Worker 50 200 20/60
                 Demographic Data.
                 57.205 Exposure to Blood/ 50 50 60/60
                 Body Fluids.
                 57.206 Healthcare Worker 50 30 15/60
                 Prophylaxis/Treatment.
                 57.207 Follow-Up Laboratory 50 50 15/60
                 Testing.
                 57.210 Healthcare Worker 50 50 10/60
                 Prophylaxis/Treatment-
                 Influenza.
                 57.300 Hemovigilance Module 500 1 85/60
                 Annual Survey.
                 57.301 Hemovigilance Module 500 12 1/60
                 Monthly Reporting Plan.
                 57.303 Hemovigilance Module 500 12 70/60
                 Monthly Reporting
                 Denominators.
                 57.305 Hemovigilance 500 10 10/60
                 Incident.
                 57.306 Hemovigilance Module 500 1 35/60
                 Annual Survey--Non-acute
                 care facility.
                 57.307 Hemovigilance 500 4 20/60
                 Adverse Reaction--Acute
                 Hemolytic Transfusion
                 Reaction.
                 57.308 Hemovigilance 500 4 20/60
                 Adverse Reaction--Allergic
                 Transfusion Reaction.
                 57.30 Hemovigilance Adverse 500 1 20/60
                 Reaction--Delayed
                 Hemolytic Transfusion
                 Reaction.
                 57.310 Hemovigilance 500 2 20/60
                 Adverse Reaction--Delayed
                 Serologic Transfusion
                 Reaction.
                 57.311 Hemovigilance 500 4 20/60
                 Adverse Reaction--Febrile
                 Non-hemolytic Transfusion
                 Reaction.
                 57.312 Hemovigilance 500 1 20/60
                 Adverse Reaction--
                 Hypotensive Transfusion
                 Reaction.
                 57.313 Hemovigilance 500 1 20/60
                 Adverse Reaction--
                 Infection.
                [[Page 53444]]
                
                 57.314 Hemovigilance 500 1 20/60
                 Adverse Reaction--Post
                 Transfusion Purpura.
                 57.315 Hemovigilance 500 1 20/60
                 Adverse Reaction--
                 Transfusion Associated
                 Dyspnea.
                 57.316 Hemovigilance 500 1 20/60
                 Adverse Reaction--
                 Transfusion Associated
                 Graft vs. Host Disease.
                 57.317 Hemovigilance 500 1 20/60
                 Adverse Reaction--
                 Transfusion Related Acute
                 Lung Injury.
                 57.318 Hemovigilance 500 2 20/60
                 Adverse Reaction--
                 Transfusion Associated
                 Circulatory Overload.
                 57.319 Hemovigilance 500 1 20/60
                 Adverse Reaction--Unknown
                 Transfusion Reaction.
                 57.320 Hemovigilance 500 1 20/60
                 Adverse Reaction--Other
                 Transfusion Reaction.
                 57.400 Outpatient Procedure 700 1 10/60
                 Component--Annual Facility
                 Survey.
                 57.401 Outpatient Procedure 700 12 15/60
                 Component--Monthly
                 Reporting Plan.
                 57.402 Outpatient Procedure 200 1 40/60
                 Component Same Day Outcome
                 Measures.
                 57.403 Outpatient Procedure 200 400 40/60
                 Component--Monthly
                 Denominators for Same Day
                 Outcome Measures.
                 57.404 Outpatient Procedure 700 100 40/60
                 Component--SSI Denominator.
                 57.405 Outpatient Procedure 700 5 40/60
                 Component--Surgical Site
                 (SSI) Event.
                 57.500 Outpatient Dialysis 7,100 1 127/60
                 Center Practices Survey.
                 57.501 Dialysis Monthly 7,100 12 5/60
                 Reporting Plan.
                 57.502 Dialysis Event...... 7,100 30 25/60
                 57.503 Denominator for 7,100 12 10/60
                 Outpatient Dialysis.
                 57.504 Prevention Process 1,760 12 75/60
                 Measures Monthly
                 Monitoring for Dialysis.
                 57.505 Dialysis Patient 860 60 10/60
                 Influenza Vaccination.
                 57.506 Dialysis Patient 860 1 5/60
                 Influenza Vaccination
                 Denominator.
                 57.507 Home Dialysis Center 430 1 30/60
                 Practices Survey.
                ----------------------------------------------------------------------------------------------------------------
                Jeffrey M. Zirger,
                Lead, Information Collection Review Office, Office of Scientific
                Integrity, Office of Science, Centers for Disease Control and
                Prevention.
                [FR Doc. 2019-21753 Filed 10-4-19; 8:45 am]
                 BILLING CODE 4163-18-P
                

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT